Regulation

Regulatory changes are coming for 2022. Christine Moundas, a partner at Ropes and Gray, gives a preview.

In a preview of their HIMSS22 presentation, Robert Jarrin, strategic advisor to ResMed Corp., and Brian Scarpelli, senior global policy counsel at the Connected Health Initiative, explain the current digital health reimbursement landscape.

Cofounder and CEO Matthew Stoudt discusses AppliedVR's De Novo clearance from November, what's next for the company and the biggest trends from 2021.

Also: Truepill launches a COVID-19 test coverage platform for insurers, and 23andMe extends its partnership with GSK.

Berlin startup targets irritable bowel syndrome and other gastrointestinal problems with a digital therapy program.

The test reports on the G84E mutation in the HOXB13 gene, which studies have shown increase a person’s risk of developing prostate cancer.

This week's top stories include the Holmes conviction for conspiracy to defraud investors and three counts of wire fraud, and Broward Health reporting an intruder accessed its network through a third-party medical service provider.

The jury found Holmes, 37, guilty of three counts of wire fraud and one count of conspiracy to commit wire fraud by lying to investors.

The new rules aim to improve access to innovative technologies.

Healthcare professionals other than physicians, dentists and veterinarians who have prescribing authority under state law can order prescription digital therapeutics. That could improve access, especially to devices that treat mental health conditions.